Schwind showcases new excimer laser

Article

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

Boasting a 1,050 Hz turbo eye tracker (5 D eye tracker), with a response time of less than three milliseconds, and other features, such as rotation balance, limbus tracking and static as well as dynamic cylcotorsion control, the company believes that it has produced the fastest and most accurate eye tracking system on the market.

Accuracy of ablation is governed by the system's "TotalTech Laser", which has a true pulse frequency of 500 Hz and two automatically adapted fluence values. Depending on the refraction to be corrected, approximately 80% of the corneal ablation is performed with a high fluence (high-speed) level, whilst fine correction takes place with a low fluence level. According to Schwind, one diopter of correction takes on average less than 2.5 seconds with the Schwind AMARIS, whilst the small beam diameter of 0.54 mm (FWHM) allows maximum precision and smooth treatment surfaces.

The laser's Intelligent Thermal Effect Control has been designed to provide dynamically adapted distribution of the laser pulses, thus reducing significant heating of the cornea and offering maximum protection to the stroma.

Other valuable features highlighted by the firm include: the continuous measurement of corneal thickness (using online pachymetry) during the procedure; the particle aspiration system, which removes energy-reducing particles; the Treatment Assistant Manager (TAM), which guides the surgeon through each treatment step; and the unique ergonomics, which optimise the treatment process and contribute to patient comfort.

"With the Schwind AMARIS, we have developed an all-rounder with unmatched high performance, thereby offering an extraordinarily high level of accuracy and safety and the first and only laser to combine all state-of-the-art technologies in one system," enthused Rolf Schwind.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.